Challenges in the care of clients with established cardiovascular disease: Lessons learned from Australian community pharmacists

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Puspitasari, Hanni P ^a,b   Aslani, Parisa ^a   Krass, Ines ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AIRLANGGA UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; AUSTRALIAN; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMMUNICATION SKILL; CONTROLLED STUDY; FEMALE; HEALTH BELIEF; HUMAN; INTEGRATIVE MEDICINE; MALE; PATIENT CARE; PHARMACIST; PHARMACIST ATTITUDE; PHARMACY; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; SECONDARY PREVENTION; SEMI STRUCTURED INTERVIEW; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; HEALTH PERSONNEL ATTITUDE; INTERVIEW; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CARDIOVASCULAR DISEASES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PHARMACIES; PHARMACISTS;

EID: 84911916518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113337     Document Type: Article

References (55)

1. Mathers CD, Boerma T, Ma Fat D (2009) Global and regional causes of death. Br Med Bull 92: 7-32. doi:10.1093/bmb/ldp028.
2. World Health Organization (2007) Prevention of cardiovascular disease: pocket guidelines for assessment and management of cardiovascular risk. Geneva: WHO Press. Available: http://www.who.int/cardiovascular-diseases/ guidelines/PocketGL.ENGLISH.AFR-D-E.rev1.pdf.
3. Robinson JG, Fox KM, Grandy S (2009) Attitudes about health and health-related behaviors in patients with cardiovascular disease or at elevated risk for cardiovascular disease. Prev Cardiol 12: 136-143. doi:10.1111/j.1751-7141.2009.00037.x.
4. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G et al. (2011) Use of secondary prevention drugs for cardiovascular disease in the community in highincome, middle-income, and low-income countries (the PURE study): a prospective epidemiological survey. Lancet 378: 1231-1243. doi:10.1016/ S0140-6736(11)61215-4.
5. Labruné M, Pathak A, Loscos M, Coudeyre E, Casillas JM et al. (2012) Therapeutic education in cardiovascular diseases: state of the art and perspectives. Ann Phys Rehabil Med 55: 322-341. doi:10.1016/j.rehab. 2012.04.003.
6. Geneau R, Stuckler D, Stachenko S, McKee M, Ebrahim S et al. (2010) Raising the priority of preventing chronic diseases: a political process. Lancet 376: 1689-1698. doi:10.1016/s0140-6736(10)61414-6.
7. White CM (2014) Pharmacists need recognition as providers to enhance patient care. Ann Pharmacother 48: 268-273. doi:10.1177/1060028013511786.
8. th ed). Madison, WI: American Institute of the History of Pharmacy.
9. Helper CD, Strand LM (1990) Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47: 533-543.
10. Health Workforce Australia (2014) Australia's health workforce series - pharmacists in focus. Adelaide: HWA. Available: https://www.hwa.gov.au/ resources/publications.
11. Pharmacy Guild of Australia (2010) The roadmap: the strategic direction for community pharmacy. Canberra: Pharmacy Guild of Australia. Available: http://www.guild.org.au/services-programs/the-roadmap.
12. Australian Government Department of Health and the Pharmacy Guild of Australia (2010) The fifth community pharmacy agreement between the Commonwealth of Australia and the Pharmacy Guild of Australia. Available: http://www.health.gov.au/internet/main/publishing.nsf/Content/fifth-community- pharmacy-agreement.
13. Puspitasari HP, Aslani P, Krass I (2013) Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease. Int J Clin Pharm 35: 1218-1228. doi:10.1007/s11096-013-9854-0.
14. Sweeny K (2007) The pharmaceutical industry in Australia: working paper no 34. Pharmaceutical industry project working paper series. Melbourne: Centre for Strategic Economic Studies Victoria University of Technology. Available: http://www.cfses.com.
15. Amariles P, Sabater-Hernandez D, Garcia-Jlmenez E, Rodriguez-Chamorro MA, Prats-Mas R et al. (2012) Effectiveness of dader method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial. J Manag Care Pharm 18: 311-323.
16. Evans CD, Watson E, Eurich DT, Taylor J, Yakiwchuk EM et al. (2011) Diabetes and cardiovascular disease intervention by community pharmacists: a systematic review. Ann Pharmacother 45: 615-628. doi:10.1345/aph.1P615.
17. Machado M, Bajcar J, Guzzo GC, Einarson TR (2007) Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and metaanalysis in diabetes management. Ann Pharmacother 41: 1569-1582. doi:10.1345/aph.1K151.
18. Machado M, Bajcar J, Guzzo GC, Einarson TR (2007) Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and metaanalysis in hypertension management. Ann Pharmacother 41: 1770-1781. doi:10.1345/aph.1K311.
19. Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR (2008) Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother 42: 1195-1207. doi:10.1345/aph.1K618.
20. Ponniah A, Anderson B, Shakib S, Doecke CJ, AngleyM(2007) Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther 32: 343-352. doi:10.1111/j.1365-2710.2007.00827.x.
21. rd ed). Thousand Oaks, CA: Sage.
22. Pharmaceutical Society of Australia (2011) Guidelines for pharmacists providing Home Medicines Review (HMR) services. Canberra: PSA. Available: http:// www.psa.org.au/download/practice-guidelines/home-medicines-reviewservices. pdf.
23. Pharmaceutical Society of Australia (2012) Guidelines for pharmacists providing medicines use review (MedsCheck) and diabetes medication management (Diabetes MedsCheck) services. Canberra: PSA. Available: http://www.psa.org. au/download/guidelines/3612-medscheck-guidelines-c.pdf.
24. Gastelurrutia MA, Benrimoj SI, Castrillon CC, de Amezua MJC, Fernandez- Llimos F et al. (2009) Facilitators for practice change in Spanish community pharmacy. Pharm World Sci 31: 32-39. doi:10.1007/s11096-008-9261-0.
25. Feletto E, Lui GWY, Armour C, Saini B (2013) Practice change in community pharmacy: using change-management principles when implementing pharmacy asthma management service in NSW, Australia. Int J Pharm Pract 21: 28-37. doi:10.1111/j.2042-7174.2012.00225.x.
26. Bryant LJM, Coster G, Gamble GD, McCormick RN (2009) General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm 5: 347-362. doi:10.1016/j.sapharm.2009.01.002.
27. Hatah E, Braund R, Duffull S, Tordoff J (2012) General practitioners' perceptions of pharmacists' new services in New Zealand. Int J Clin Pharm 34: 364-373. doi:10.1007/s11096-012-9617-3.
28. Wong FYY, Chan FWK, You JHS, Wong ELY, Yeoh EK (2011) Patient selfmanagement and pharmacist-led patient self-management in Hong Kong: a focus group study from different healthcare professionals' perspectives. BMC Health Serv Res 11: 121. doi:10.1186/1472-6963-11-121.
29. Bereznicki B, Peterson G, Jackson S, Haydn Walters E, DeBoos I et al. (2011) Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study. J Clin Pharm Ther 36: 348-355. doi:10.1111/ j.1365-2710.2010.01187.x.
30. Bissell P, Blenkinsopp A, Short D, Mason L (2008) Patients' experiences of a community pharmacy-led medicines management service. Health Soc Care Community 16: 363-369. doi:10.1111/j.1365-2524.2007.00749.x.
31. Grindrod KA, Rosenthal M, Lynd L, Marra CA, Bougher D et al. (2009) Pharmacists' perspectives on providing chronic disease management services in the community - part I: current practice environment. Can Pharm J (Ott) 142: 234-239. doi:10.3821/1913-701x-142.5.234.
32. Holland RW, Nimmo CM (1999) Transitions, part 1: beyond pharmaceutical care. Am J Health Syst Pharm 56: 1758-1764.
33. Chisholm-Burns MA, Lee JK, Spivey CA, Slack M, Herrier RN et al. (2010) US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 48: 923-933.
34. Stergachis A, Gardner JS, Anderson MT, Sullivan SD (2002) Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc (Wash) 42: 743-752.
35. Grover A, Niecko-Najjum LM (2013) Primary care team: are we there yet? Implications for workforce planning. Acad Med 88: 1827-1829. doi:10.1097/ ACM.0000000000000028.
36. Chung VCH, Ma PHX, Hong LC, Griffiths SM (2012) Organizational determinants of interprofessional collaboration in integrative health care: systematic review of qualitative studies. PLoS ONE 7: e50022. doi:10.1371/ journal.pone.0050022.
37. th ed). Curtin, ACT: Consumers' Health Forum of Australia Inc. Available: https://www.chf.org.au/crr-237-guidelines-consumer-reps.chf.
38. D'Amour D, Goulet L, Labadie JF, Martin-Rodriguez LS, Pineault R (2008) A model and typology of collaboration between professionals in healthcare organizations. BMC Health Serv Res 8: 188. doi:10.1186/1472-6963-8-188.
39. Browne S, Macdonald S, May CR, Macleod U, Mair FS (2014) Patient, carer and professional perspectives on barriers and facilitators to qualitative care in advanced heart failure. PLoS ONE 9: e93288. doi:10.1371/journal.pone.0093288.
40. Mak VSL, Clark A, Poulsen JH, Udengaard KU, Gilbert AL (2012) Pharmacists' awareness of Australia's health care reforms and their beliefs and attitudes about their current and future roles. Int J Pharm Pract 20: 33-40. doi:10.1111/j.2042-7174.2011.00160.x.
41. West MA (2007) Teamwork. In: Ritzer G, editor. Blackwell encyclopedia of sociology. Blackwell Reference Onl ine. Available: http://www. sociologyencyclopedia.com.ezproxy1.library.usyd.edu.au.
42. Berbatis CG, Sunderland VB, Joyce A, Bulsara MK, Mills C (2007) Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project. Int J Pharm Pract 15: 185-191. doi:10.1211/ijpp.15.3.0005.
43. Blake KB, Madhavan SS (2010) Perceived barriers to provision of Medication Therapy Management Services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother 44: 424-431. doi:10.1345/aph.1M386.
44. Doucette WR, Nevins JC, Gaither C, Kreling DH, Mott DA et al. (2012) Organizational factors influencing pharmacy practice change. Res Social Adm Pharm 8: 274-284. doi:10.1016/j.sapharm.2011.07.002.
45. Chui MA, Mott DA, Maxwell L (2012) A qualitative assessment of a community pharmacy cognitive pharmaceutical services program, using a work system approach. Res Social Adm Pharm 8: 206-216. doi:10.1016/j.sapharm.2011.06.001.
46. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Hopp TR et al. (2005) Understanding practice change in community pharmacy: a qualitative study in Australia. Res Social Adm Pharm1: 546-564. doi:10.1016/j.sapharm.2005.09.003.
47. Smith M, Bates D, Bodenheimer T (2013) Pharmacists belong in accountable care organizations and integrated care teams. Health Aff 32: 1963-1970. doi:10.1377/hlthaff.2013.0542.
48. Mossialos E, Naci H, Courtin E (2013) Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? Health Policy 111: 135-148. doi:10.1016/j.healthpol.2013.04.003.
49. d'Amboise G, Muldowney M (1988) Management theory for small business: attempts and requirements. Acad Manage Rev 13: 226-240.
50. Benson A, Cribb A, Barber N (2009) Understanding pharmacists' values: a qualitative study of ideals and dilemmas in UK pharmacy practice. Soc Sci Med 68: 2223-2230. doi:10.1016/j.socscimed.2009.03.012.
51. Jacobs S, Ashcroft DM, Hassell K (2011) Culture in community pharmacy organisations: what can we glean from the literature? J Health Organ Manag 25: 420-454. doi:10.1108/14777261111155047.
52. Kerner J (2008) Integrating research, practice, and policy: what we see depends on where we stand. J Public Health Manag Pract 14: 193-198.
53. Swanson RC, Cattaneo A, Bradley E, Chunharas S, Atun R et al. (2012) Rethinking health systems strengthening: key systems thinking tools and strategies for transformational change. Health Policy Plan 27 (suppl 4): iv54-iv61. doi:10.1093/heapol/czs090.
54. Zellmer WA (2012) The future of health-system pharmacy: opportunities and challenges in practice model change Ann Pharmacother 46: S41-S45. doi:10.1345/aph.1Q805.
55. Martin-Calero MJ, Machuca M, Murillo MD, Cansino J, Gastelurrutia MA et al. (2004) Structural process and implementation programs of pharmaceutical care in different countries. Curr Pharm Des 10: 3969-3985.